Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immunic | IMUX | Jan 10, 2025 | 1.05 | -4.55 |
ImmunityBio | IBRX | Jan 10, 2025 | 2.42 | -5.47 |
Immunocore ADR | IMCR | Jan 10, 2025 | 30.40 | +0.56 |
Immunome | IMNM | Jan 10, 2025 | 10.60 | -0.56 |
ImmunoPrecise Antibodies | IPA | Jan 10, 2025 | 0.53 | -2.85 |
Immunovant | IMVT | Jan 10, 2025 | 23.48 | -0.63 |
Immutep ADR | IMMP | Jan 10, 2025 | 2.01 | +0.50 |
Imperial Oil | IMO | Jan 10, 2025 | 66.86 | +0.84 |
Imperial Petroleum | IMPP | Jan 10, 2025 | 3.30 | +3.13 |
Imperial Petroleum A Pref | IMPPP | Jan 10, 2025 | 25.00 | +0.32 |
Impinj | PI | Jan 10, 2025 | 143.62 | -4.45 |
Imunon | IMNN | Jan 10, 2025 | 0.90 | -1.06 |
IN8bio | INAB | Jan 10, 2025 | 0.32 | +3.42 |
Inari Medical | NARI | Jan 10, 2025 | 79.29 | -0.01 |
Incannex Healthcare ADR | IXHL | Jan 10, 2025 | 1.85 | +1.09 |
Inception Growth Acquisition | IGTA | Jan 10, 2025 | 11.75 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Jan 10, 2025 | 12.00 | 0.00 |
Income Opportunity Realty Investors | IOR | Jan 10, 2025 | 18.16 | 0.00 |
Incyte | INCY | Jan 10, 2025 | 70.54 | -3.54 |
Indaptus Therapeutics | INDP | Jan 10, 2025 | 0.95 | -2.06 |
Independence Realty Trust | IRT | Jan 10, 2025 | 18.23 | -3.03 |
Independent Bank | INDB | Jan 10, 2025 | 60.31 | -3.27 |
Independent Bank | IBCP | Jan 10, 2025 | 32.75 | -2.70 |
Independent Bank Group | IBTX | Jan 10, 2025 | 60.67 | 0.00 |
India Bull 3X Direxion | INDL | Jan 10, 2025 | 56.23 | -4.27 |
India Consumer Egshares | INCO | Jan 10, 2025 | 63.17 | -1.71 |
India Earnings Wisdomtree | EPI | Jan 10, 2025 | 43.89 | -2.49 |
India Fund | IFN | Jan 10, 2025 | 15.92 | -1.67 |
India Powershares | PIN | Jan 10, 2025 | 25.06 | -2.30 |
Indie Semiconductor A | INDI | Jan 10, 2025 | 4.16 | -2.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.